Bayer shed approximately 4,700 employees in 2025, dropping from 92,815 to 88,078 staff by year end. Cuts affected all functional areas including production, marketing, R&D, and administration, with personnel expenses declining by approximately $842 million.
All entries for: Bayer
August 7, 2025
Bayer
Layoffs
Whippany, NJ
50,001+ employees
Workforce cuts continue at Bayer, with CEO Bill Anderson announcing on the company’s second-quarter earnings call on Aug. 6 that it expects more layoffs to come. These would follow the 2,000 employees it said it was letting go during first-quarter earnings and around 11,000 total since Bayer initiated a sweeping reorganization initiative in July 2023.
Disease Area: Cardiology, Hematology, Multiple, Oncology
Drug Type: Biologic, Small Molecule
May 14, 2025
Bayer
Layoffs
Whippany, NJ
50,001+ employees
Bayer laid off some 2,000 employees in the first quarter of 2025, CEO Bill Anderson revealed in a media call May 13, alongside the presentation of the company’s first quarter earnings results.
Disease Area: Cardiology, Hematology, Multiple, Neurological Diseases, Oncology
Drug Type: Biologic, Small Molecule